Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease
Reexamination Certificate
2005-01-18
2005-01-18
Harris, Alana M. (Department: 1642)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Transferase other than ribonuclease
C530S300000, C530S350000, C530S402000, C424S192100, C424S193100, C514S002600
Reexamination Certificate
active
06844177
ABSTRACT:
The present invention relates to PTP04 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animal containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for PTP04 related diseases or conditions characterized by an abnormal interaction between a PTP04 binding partner.
REFERENCES:
patent: 4343940 (1982-08-01), Kreighbaum et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4447608 (1984-05-01), Jones et al.
patent: 4757072 (1988-07-01), Kabbe et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 5168050 (1992-12-01), Hammonds, Jr. et al.
patent: 5217999 (1993-06-01), Levitzki et al.
patent: 5283173 (1994-02-01), Fields et al.
patent: 5302606 (1994-04-01), Spada et al.
patent: 5316553 (1994-05-01), Kaul et al.
patent: 5330992 (1994-07-01), Eissenstat et al.
patent: 5602171 (1997-02-01), Tang et al.
patent: 6238902 (2001-05-01), Cheng et al.
patent: 0 520 722 (1992-12-01), None
patent: 0 562 734 (1993-09-01), None
patent: 0 566 226 (1993-10-01), None
patent: 9115495 (1991-10-01), None
patent: 9220642 (1992-11-01), None
patent: 9221660 (1992-12-01), None
patent: 9309236 (1993-05-01), None
patent: WO 93 10242 (1993-05-01), None
patent: 9403427 (1994-02-01), None
patent: 9414808 (1994-07-01), None
patent: 9423039 (1994-10-01), None
patent: WO 95 06735 (1995-03-01), None
patent: 9622976 (1996-08-01), None
patent: WO 96 34985 (1996-11-01), None
Accession No. Q93095. Database SPTREMBL, Feb. 01, 1997, Dayton, M.A. et al.*
Shantz and Pegg, Int J of Biochem and Cell Biol., 1999, vol. 31, pp. 107-122.*
McClean and Hill, Eur J of Cancer, 1993, vol. 29A, pp. 2243-2248.*
Fu et al, EMBO Journal. 1996, vol. 15, pp. 4392-4401.*
Bowie et al., Science, 247: 1306-1310, 1990.*
Burgess et al, J. Cell Biology. 111 : 2129-2138, 1990.*
Lazar et al, Molecular and Cellular Biology, 8: 1247-1252, 1988.*
EMBL Database Entry HS1185621; Accession No. AA281242; Apr. 4, 1997; Robert Strausberg.
Aoki, et al., “The Novel Protein-Tyrosine Phosphatase PTP20 Is A Positive Regulator of OC12 Cell Neuronal Differentiation”,Journal of Biological Chemistry, vol. 271, No. 46 29422-29426 (1996).
Saras, et al., “Cloning And Characterization Of PTPL1, A Protein Tyrosine Phosphatase With Similarities to Cytoskeletal-Associated Proteins.”Journal of Biological Chemistry, vol. 269, No. 39 24082-24089 (1994).
Matthews, et al., “Characterization Of Hematopoietic Intracellular Protein Tyrosine Phosphatases: Description Of A Phosphatase Containing An SH2 Domain And Another Enriched In Proline-, Glutamic Acid-, Serine-, and Threonine-rich Sequences.”Molecular And Cellular Biology, vol. 12, No. 5 2396-2405 (1992).
Maekawa, et al., “Molecular Cloning Of A Novel Protein-Tyrosine Phosphatase Containing A Membrane-Binding Domain And glgf Repeats.”FEBS Letters, vol. 337, 200-206 (1994).
Abe et al., “Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR5 Coupled to Inositol Phosphate/ca2+Signal.”, J. Biol. Chem. 267 (19): 13361-13368 (1992).
Allen et al., “Modulation of CD4 by suramin.”, Clin. Exp. Immunol. 91: 141-146 (1991).
Altschul et al., “Basic Local Alignment Search Tool.”. J. Mol. Biol. 215: 403-410 (1990).
Anafi et al., “Tyrphostin-Induced Inhibition of p210ber-ablTyrosine Kinase Activity Induces K562 to Differentiate.”, Blood 82: 3524-3529 (1993).
Ausubel et al., Index to Current Protocols in Molecular Biology (1989).
Baker et al., “Induction of acetylcholine receptor clustering by native polystyrene beads.”, Journal of Cell Science 102: 543-555 (1992).
Barker et al., “In vitro activity of non-glutamate containing quinazoline-based thymidylate synthase inhibitors.” Proceedings of the American Association for Cancer Research 32: 327 at abstract No. 1939 (1991).
Bayer et al., “The Avidin-Biotin Complex in Affinity Cytochemistry.”, Meth. Enzym. 62: 308 (1979).
Benoist et al., “In vivo sequence requirements of the SV40 early promoter region.”, Nature 290: 304-310 (1981).
Bertino, “Toward Improved Selectivity in Cancer Chemotherapy: The Richard and Hinda Rosenthal Foundation Award Lecture.” Cancer Research 39: 293-304 (1979).
Bilder et al., “Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.” Am. J. Physiol. 260 (Cell Physiol 29): C721-C730 (1991).
Bollon et al., “DNA Transformation Efficiency of Various Bacterial and Yeast Host-Vector Systems.” J. Clin. Hematol. Oncoll. 10: 39-48 (1980).
Botstein et al., “Making Mutations In Vitro and Putting Them Back Into Yeast.” Miami Wntr. Symp. 19: 265-274 (1982).
Brinster et al., “Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs.” Proc. Natl. Acad. Sci. USA 82: 4428-4442 (1985).
Broach, “The Yeast Plasmid 2μ Circle.” Cell 28: 203-204 (1982).
Broach, In: The Moleclar Biology of the Yeast Saccharomyces: Life Cycle and Inheritance, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 445-470.
Brunton et al., “Anti-tumour activity of novel tryphostins in breast cancer cells.”, Proceedings of the American Association for Cancer Research 33: 558 at abstract No. 3335 (1992).
Bryckaert et al., “Inhibition of Platelet-Derived Growth Factor-Induced Mitogenesis and Tyrosine Kinase Activity in Cultured Bone Marrow Fibroblasts by Tryphostins.” Exp. Cell Research 199: 255-261 (1992).
Bullock et al., Techniques in Immunocytochemistry, Academic Press, Orlando, FL vol. 1 (1982). vol. 2 (1983). vol. 3 (1985).
Burke et al., “Arylamides of Hydroxylated Isoquinolines as Protein-Tyrosine Kinase Inhibitors.”, Bioorganic & Medical Chemistry Letter 2 (12): 1771-1774 (1992.
Burke et al., “Bicyclic Compounds as Ring-Constrained Inhibitors of Protein-Tyrosine Kinase p56lck 1.” Journal of Medicinal Chemistry 36 (4): 425-432 (1993).
Campbell, Monoclonal Antibody Technology: Laboratory Techniques in Biochemistry and Molecular Biology, Elsevier Science Publishers, Amsterdam, The Netherlands (1984).
Capecchi MR, “High Efficiency by Direct Microinjection of DNA into Cultured Mammalian Cells.” Cell 22: 479-488 (1980).
Capecchi, “Altering the Genome by Homologous Recombination.”, Science 244: 1288-1292 (1989).
Cenatiempo, “Prokaryotic Gene Expression In Vitro: Transcription-Translantion Coupled Systems.”, Biochimie 68: 505-516 (1986).
Chard, “An Introduction to Radioimmunoassay and Related Techniques.” Elsevier Science Publishers, Amsterdam, The Netherlands (1986).
Chater et al., In: Sixth International Symposium on Actinomycetales Biology, Akademiai Kaido, Budapest, Hungary (1986) pp. 45-54.
Chen et al., “High-Efficiency Transformation of Mammalian Cells by Plasmid DNA.”,Molecular and Cellular Biology 7 (8): 2745-2752 (1987).
Chu G. et al., “Electroporation for the Efficient Transfection of Mammalian Cells with DNA.”, Nucleic Acids Res. 15: 1311-1326 (1987).
Curiel et al., “Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated Endocytosis Pathway.” Am. J. Respir. Cell. Mol. Biol. 6: 247-252 (1992).
Curtin et al., “Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717.” Br. J. Cancer 53: 361-368 (1986).
Dolle et al., “5,7-Dimethoxy-3-(4-pyridinyl)) quinoline is a Potent and Selective Inhibitor of Human Vascular—Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase.” J. Med. Chem. 37: 2627-2629 (1994).
Dong et al., “Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity.” Journal of Leukocyte Biolog
Jallal Bahija
Plowman Gregory D.
Burrous Beth A.
Harris Alana M.
Holleran Anne L.
Sugen Inc.
LandOfFree
Diagnosis and treatment of PTP04 related disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis and treatment of PTP04 related disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of PTP04 related disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3406442